World Cancer Day – February 4th, 2021

GOC is a proud partner of the New Normal Same Cancer campaign!
On #WorldCancerDay, we’re encouraging Canadians to reprioritize cancer care during the pandemic. Cancer does not stop for a pandemic!

Follow us on Twitter and Instagram to keep up with the campaign!

Ovarian Cancer Awareness Month

Reference Materials-BRCA Course for patients and families (October 2019)

PARP Inhibitors: What you need to know (October 2018)

The CoP in BRCA is pleased to share its newest publication – “PARP Inhibitors: What you need to know”. This brochure explores several questions such as the side effects of PARP inhibitors and what can be done about them, and will serve as a quick go-to guide.


Precare Gynecological Surgery Guide (July 2018)

Enhanced Recovery After Surgery (ERAS) protocols have resulted in shorter length of hospital stay by 30% to 50% and similar reductions in complications, while readmissions and costs are reduced.

The Society of Gynecologic Oncology of Canada (GOC) endorses the following animated feature on the Gynecologic ERAS Guide.

For more information, visit


Canadian Cancer Society

Foundation for Women’s Cancers

Ovarian Cancer Canada



Alberta Cancer Foundation

Alberta Health Services

British Columbia

BC Cancer Foundation

BC Cancer Agency support programs

Patient/Public info—Coping with Cancer

Patient and Family Counselling Services—BC cancer agency
1-800-663-3333 ext. 2194


Cancer Care Manitoba

New Brunswick

New Brunswick Cancer Network

Newfoundland and Labrador

Canadian Cancer Society

Northwest Territories

Cancer Chat Canada

Cancer View

Nova Scotia

Cancer Care Nova Scotia


Canadian Cancer Society


Cancer Care Ontario


Prince Edward Island


Canadian Cancer Society

Living Well With Cancer Network

Réseau Bien Vivre Avec Un Cancer


Saskatchewan Cancer Agency


Canadian Cancer Society

Yukon Cancer Navigator

In the Yukon, a Cancer Navigator is available to assist in providing information on travel, accommodations and community based resources.